[go: up one dir, main page]

Мусаева et al., 2023 - Google Patents

CHARACTERISTICS OF BACTERIAL MICROFLORA IN RATS WITH MASSIVE INFECTION OF THE ABDOMINAL CAVITY

Мусаева et al., 2023

View PDF
Document ID
6979955348742031634
Author
Мусаева
Абдрешов
Егорова
Ешмуханбет
Есенова
Горчаков
Демченко
Publication year
Publication venue
Микробиология және вирусология

External Links

Snippet

Isolation of pathogens of infectious diseases isolated from animals, their identification based on the study of biological properties, determination of antibiotic resistance is an urgent task. During of inflammation of the abdominal cavity on a biological system in vivo, cultures of …
Continue reading at www.imv-journal.kz (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • C12Q1/04—Determining presence or kind of micro-organism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Bacteriophages
    • C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Similar Documents

Publication Publication Date Title
CN113583971B (en) Salmonella bacteriophage capable of simultaneously cracking escherichia coli and application thereof
Marouf et al. Molecular detection of multidrug-resistant Pseudomonas aeruginosa of different avian sources with pathogenicity testing and in vitro evaluation of antibacterial efficacy of silver nanoparticles against multidrug-resistant P. aeruginosa
Kebede Pseudomonas infection in chickens
Lenchenko et al. Bird immunobiological parameters in the dissemination of the biofilm-forming bacteria Escherichia coli
Mussayeva et al. Salmonella sheep abortion: Distribution, diagnosis, and control measures
Мусаева et al. CHARACTERISTICS OF BACTERIAL MICROFLORA IN RATS WITH MASSIVE INFECTION OF THE ABDOMINAL CAVITY
Usman et al. Occurrence of multi-drug resistant Enterobacteriaceae in cultured Clarias gariepinus (African catfish) in Kano metropolis, Nigeria
Ribeiro et al. Phenotypic and genotypic characterization of Prototheca zopfii in a dog with enteric signs
Lakho et al. Efficacy of quinolones and cephalosporins against antibiogram of Escherichia coli isolated from chickens
Amos et al. Isolation, identification and antimicrobial susceptibility profile of Pseudomonas species isolated from pig (Sus scrofa) feces in owo metropolis
Lateif et al. Genotypic characterization of Escherichia coli isolated from infected chicken in Basrah, Iraq
Ajayi et al. Antibiotic resistance among bacteria isolated from pigs in selected farms in Ekiti State, Nigeria
Neidorf et al. Diagnosis and treatment of flexibacteriosis of koi carp (Cyprinus carpio koi)
Rasheed et al. Isolation, identification and sensitivity of Mannheimia haemolytica from Ewes udder with clinical mastitis
Mustafa et al. Enterobacter agglomerans-a cause of stomatitis in a snake.
Qadi et al. Colistin and Antimicrobial Resistance among Gram-negative Bacteria isolated from Poultry in West Bank, Palestine
Borovyc et al. Evaluation of contamination of cow milk with various conditionally pathogenic microflora for mastitis: genera Staphylococcus
Yessenova et al. STUDY OF THE MICROBIAL LANDSCAPE OF PERITONEAL EXUDATE IN ABDOMINAL INFLAMMATION
Purkayastha et al. Cultural and biochemical characterization of sheep Escherichia coli isolated from in and around Bau campus
MOHANTO PREVALENCE AND PROFILING OF ANTIBIOTIC SENSITIVITY OF A KEY PUBLIC HEALTH PLAYER ESCHERICHIA COLI FROM COMPANION ANIMAL IN DHAKA CITY
Kuryata et al. Fluoroquinolone-resistant Escherichia coli strains in animal and poultry feed from Ukrainian feed-producing enterprises
CHICKEN M TARAKESWARA RAO
Balakrishnan et al. Isolation and identification of Clostridium chauvoei from cattle suffered from black quarter
RU2640251C2 (en) Method for production of nutrient medium for transportation of pathological material containing animal necrobacteriosis excitor
ISLAM COLIFORM AND STAPHYLOCOCCAL MASTITIS IN COWS RISK FACTORS AND TRENDS IN ANTIMICROBIAL RESISTANCE